References
- Dawson D J, Khan A N, Miller V, Ratcliffe J P, Shreeve D R. Detection of inflammatory bowel disease in adults and children: evaluation of a new isotopic technique. Br Med J 1985; 156: 783–786
- Zahavi I, Avidor I, Marcus H, et al. Effects of sucralfate in experimental colitis in the rat. Gastroenterology 1987; 92: A1707
- Carling L, Kagevi T, Boarvall E. Sucralfate enema–effective in IBD?. Endoscopy 1986; 18: 115
- Brogden R N, Heel R C, Speight T M, Avery G S. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs 1984; 27: 194–209
- Giesing D H, Bighley L D, Lies R L. Effect of food and antacid on binding sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. J Clin Gastroenterol 1981; 3(suppl 12)111–116
- Nakazawa S, Nagashima R, Samloff I M. Selective binding of sucralfate to gastric ulcer in man. Dig DisSci 1981; 26: 287–300
- George A, Merrik M V, Palmer K R. 99-Tc-sucral-fate scintigraphy and colonic disease. Br Med J 1987; 295: 578
- Crama-Bohbouth G E, Arndt J W, Pena A S, et al. Is radiolabeled sucralfate scintigraphy of any use in the diagnosis of inflammatory bowel disease?. Nucl Med Comm 1988; 9: 591–595
- Shea-Donohue T, Steel L, Montcalm E, Dubois A. Gastric protection by sucralfate. Role of mucus and prostaglandins. Gastroenterology 1986; 91: 660–666
- Guslandi M, Bellarin E, Cambielli M, Tittobello A. Stimulation of mucus output. A further mode of action of sucralfate. Gastroenterology 1982; 84: A1177
- Slomiany B L, Laszewicz W, Takagi A, Slomiany A. In vitro inhibition of peptic degradation of gastric mucus by sucralfate. Gastroenterology 1985; 88: A1590
- Hollander D, Tarnawaski A, Krause J W, Gergely H. Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural, and functional time sequence analysis. Gastroenterology 1985; 88: 366–374
- Hollander D, Tarnawski A, Gergely H, Zipser R D. Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin mediated process?. Scand J Gastroenterol 1984; 19(suppl 101)97–102
- Konturek S J, Kwiencien N, Obtulowicz W, Kopp B, Olesky J. Double-blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man. Gut 1986; 27: 1450–1456
- Yostrida N, Teras N, Nagashima R. Sucralfate, a basic aliminium salt of sucrose sulphate: iv interaction with enzyme pepsin. Arzneimittelforsch 1980; 30: 78–80
- Salmoff I M, O'Dell C. Inhibition of peptic activity by sucralfate. Am J Med 1985; 79(suppl 20)15–18
- Graham D Y, Sackmen J W, Giesing D H, Runser D J. In vitro absorption of bile salts and aspirin to sucralfate. Dig Dis Sci 1984; 29: 402–406
- McIntyre P B, Macrae F A, Borghouse L, English J, Lennard-Jones J E. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 1985; 26: 822–824
- Sutherland L R, Martin F, Greer S, et al. 5-amino-salicylic acid enema in the treatment of distal ulcerative colitis, procto sigmoiditis and proctitis. Gastroenterology 1987; 92: 1894–1898
- Selby W S, Barr G D, Ireland A, Mason C H, Jewell D P. Olsalazine in active ulcerative colitis. Br Med J 1985; 291: 1373–1375
- Palmer R K, Goepel J R, Holdsworth C D. Sul-phasalazine retention enemas in ulcerative colitis: a double-blind trial. Br Med J 1981; 282: 1571–1573
- Campieri P, Gionchetti P, Bellinzzi A, et al. 5-Aminosalicylic acid, sucralfate and placebo enemas in the treatment of distal ulcerative colitis. Gastroenterology 1988; 94: A58